
### [MONDO:0016105](http://purl.obolibrary.org/obo/MONDO_0016105)
**Label:** acquired skeletal muscle disease

**Subclasses:** [MONDO:0016126](http://purl.obolibrary.org/obo/MONDO_0016126) (viral myositis), [MONDO:0016367](http://purl.obolibrary.org/obo/MONDO_0016367) (dermatomyositis), [MONDO:0016125](http://purl.obolibrary.org/obo/MONDO_0016125) (infectious, fungal or parasitic myopathy), [MONDO:0001907](http://purl.obolibrary.org/obo/MONDO_0001907) (adult dermatomyositis), [MONDO:0016128](http://purl.obolibrary.org/obo/MONDO_0016128) (parasitic myositis), [MONDO:0018942](http://purl.obolibrary.org/obo/MONDO_0018942) (macrophagic myofasciitis), [MONDO:0016127](http://purl.obolibrary.org/obo/MONDO_0016127) (bacterial myositis), [MONDO:0016124](http://purl.obolibrary.org/obo/MONDO_0016124) (drug and/or toxic myopathy), [MONDO:0009993](http://purl.obolibrary.org/obo/MONDO_0009993) (embryonal rhabdomyosarcoma (disease)), [MONDO:0016123](http://purl.obolibrary.org/obo/MONDO_0016123) (muscular tumor), [MONDO:0009994](http://purl.obolibrary.org/obo/MONDO_0009994) (alveolar rhabdomyosarcoma (disease)), [MONDO:0015271](http://purl.obolibrary.org/obo/MONDO_0015271) (idiopathic camptocormia), [MONDO:0016282](http://purl.obolibrary.org/obo/MONDO_0016282) (rhabdomyosarcoma of the cervix uteri), [MONDO:0004012](http://purl.obolibrary.org/obo/MONDO_0004012) (adult botryoid rhabdomyosarcoma), [MONDO:0004013](http://purl.obolibrary.org/obo/MONDO_0004013) (adult vagina botryoid rhabdomyosarcoma), [MONDO:0014945](http://purl.obolibrary.org/obo/MONDO_0014945) (myopathy, distal, with rimmed vacuoles; DMRV), [MONDO:0016609](http://purl.obolibrary.org/obo/MONDO_0016609) (inflammatory myopathy with abundant macrophages), [MONDO:0008054](http://purl.obolibrary.org/obo/MONDO_0008054) (juvenile dermatomyositis), [MONDO:0002849](http://purl.obolibrary.org/obo/MONDO_0002849) (liver rhabdomyosarcoma), [MONDO:0018654](http://purl.obolibrary.org/obo/MONDO_0018654) (idiopathic dropped head syndrome), [MONDO:0019344](http://purl.obolibrary.org/obo/MONDO_0019344) (Antisynthetase syndrome), [MONDO:0018011](http://purl.obolibrary.org/obo/MONDO_0018011) (juvenile overlap myositis), [MONDO:0009227](http://purl.obolibrary.org/obo/MONDO_0009227) (myofibromatosis, infantile, 1), [MONDO:0018010](http://purl.obolibrary.org/obo/MONDO_0018010) (juvenile idiopathic inflammatory myopathy), [MONDO:0021142](http://purl.obolibrary.org/obo/MONDO_0021142) (acquired rippling muscle disease), [MONDO:0006123](http://purl.obolibrary.org/obo/MONDO_0006123) (cardiac rhabdomyoma (disease)), [MONDO:0018845](http://purl.obolibrary.org/obo/MONDO_0018845) (focal myositis), [MONDO:0009175](http://purl.obolibrary.org/obo/MONDO_0009175) (eosinophilic fasciitis (disease)), [MONDO:0019734](http://purl.obolibrary.org/obo/MONDO_0019734) (juvenile polymyositis), [MONDO:0016100](http://purl.obolibrary.org/obo/MONDO_0016100) (rippling muscle disease with myasthenia gravis), [MONDO:0014122](http://purl.obolibrary.org/obo/MONDO_0014122) (myofibromatosis, infantile, 2), [MONDO:0020122](http://purl.obolibrary.org/obo/MONDO_0020122) (idiopathic inflammatory myopathy), [MONDO:0016260](http://purl.obolibrary.org/obo/MONDO_0016260) (uterine corpus rhabdomyosarcoma), [MONDO:0002856](http://purl.obolibrary.org/obo/MONDO_0002856) (gallbladder rhabdomyosarcoma), [MONDO:0000756](http://purl.obolibrary.org/obo/MONDO_0000756) (parameningeal embryonal rhabdomyosarcoma), [MONDO:0002859](http://purl.obolibrary.org/obo/MONDO_0002859) (breast rhabdomyosarcoma), [MONDO:0002858](http://purl.obolibrary.org/obo/MONDO_0002858) (ovary rhabdomyosarcoma), [MONDO:0002853](http://purl.obolibrary.org/obo/MONDO_0002853) (rectum rhabdomyosarcoma), [MONDO:0002578](http://purl.obolibrary.org/obo/MONDO_0002578) (botryoid rhabdomyosarcoma), [MONDO:0002577](http://purl.obolibrary.org/obo/MONDO_0002577) (bile duct rhabdomyosarcoma), [MONDO:0004513](http://purl.obolibrary.org/obo/MONDO_0004513) (adult pleomorphic rhabdomyosarcoma), [MONDO:0002574](http://purl.obolibrary.org/obo/MONDO_0002574) (prostate embryonal rhabdomyosarcoma), [MONDO:0002576](http://purl.obolibrary.org/obo/MONDO_0002576) (embryonal extrahepatic bile duct rhabdomyosarcoma), [MONDO:0002851](http://purl.obolibrary.org/obo/MONDO_0002851) (mediastinum rhabdomyosarcoma), [MONDO:0002850](http://purl.obolibrary.org/obo/MONDO_0002850) (central nervous system rhabdomyosarcoma), [MONDO:0004233](http://purl.obolibrary.org/obo/MONDO_0004233) (childhood pleomorphic rhabdomyosarcoma), [MONDO:0016824](http://purl.obolibrary.org/obo/MONDO_0016824) (myofibromatosis), [MONDO:0016610](http://purl.obolibrary.org/obo/MONDO_0016610) (idiopathic eosinophilic myositis), [MONDO:0016099](http://purl.obolibrary.org/obo/MONDO_0016099) (overlap myositis), [MONDO:0019127](http://purl.obolibrary.org/obo/MONDO_0019127) (polymyositis), [MONDO:0017386](http://purl.obolibrary.org/obo/MONDO_0017386) (pleomorphic rhabdomyosarcoma), [MONDO:0019202](http://purl.obolibrary.org/obo/MONDO_0019202) (myxofibrosarcoma), [MONDO:0019444](http://purl.obolibrary.org/obo/MONDO_0019444) (Trichinellosis), [MONDO:0016095](http://purl.obolibrary.org/obo/MONDO_0016095) (vaginal rhabdomyosarcoma), [MONDO:0016098](http://purl.obolibrary.org/obo/MONDO_0016098) (immune-mediated necrotizing myopathy), [MONDO:0016130](http://purl.obolibrary.org/obo/MONDO_0016130) (fungal myositis), [MONDO:0002864](http://purl.obolibrary.org/obo/MONDO_0002864) (anus rhabdomyosarcoma), [MONDO:0002863](http://purl.obolibrary.org/obo/MONDO_0002863) (mixed type rhabdomyosarcoma), [MONDO:0003994](http://purl.obolibrary.org/obo/MONDO_0003994) (vagina botryoid rhabdomyosarcoma), [MONDO:0002860](http://purl.obolibrary.org/obo/MONDO_0002860) (testis rhabdomyosarcoma), [MONDO:0003992](http://purl.obolibrary.org/obo/MONDO_0003992) (childhood botryoid rhabdomyosarcoma), [MONDO:0003993](http://purl.obolibrary.org/obo/MONDO_0003993) (childhood vagina botryoid rhabdomyosarcoma), [MONDO:0002581](http://purl.obolibrary.org/obo/MONDO_0002581) (spindle cell rhabdomyosarcoma), [MONDO:0006389](http://purl.obolibrary.org/obo/MONDO_0006389) (prostate rhabdomyosarcoma), [MONDO:0005212](http://purl.obolibrary.org/obo/MONDO_0005212) (rhabdomyosarcoma (disease)), [MONDO:0011603](http://purl.obolibrary.org/obo/MONDO_0011603) (GNE myopathy), 

**Mapped go classes:** [GO:0006047](http://purl.obolibrary.org/obo/GO_0006047) (UDP-N-acetylglucosamine metabolic process), [GO:0002244](http://purl.obolibrary.org/obo/GO_0002244) (hematopoietic progenitor cell differentiation), [GO:0048484](http://purl.obolibrary.org/obo/GO_0048484) (enteric nervous system development), [GO:0050793](http://purl.obolibrary.org/obo/GO_0050793) (regulation of developmental process), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0072223](http://purl.obolibrary.org/obo/GO_0072223) (metanephric glomerular mesangium development), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0001945](http://purl.obolibrary.org/obo/GO_0001945) (lymph vessel development), [GO:0060594](http://purl.obolibrary.org/obo/GO_0060594) (mammary gland specification), [GO:0005080](http://purl.obolibrary.org/obo/GO_0005080) (protein kinase C binding), [GO:2000491](http://purl.obolibrary.org/obo/GO_2000491) (positive regulation of hepatic stellate cell activation), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0006054](http://purl.obolibrary.org/obo/GO_0006054) (N-acetylneuraminate metabolic process), [GO:0000989](http://purl.obolibrary.org/obo/GO_0000989) (transcription factor activity, transcription factor binding), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043114](http://purl.obolibrary.org/obo/GO_0043114) (regulation of vascular permeability), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0004553](http://purl.obolibrary.org/obo/GO_0004553) (hydrolase activity, hydrolyzing O-glycosyl compounds), [GO:0000983](http://purl.obolibrary.org/obo/GO_0000983) (transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0035947](http://purl.obolibrary.org/obo/GO_0035947) (regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0048015](http://purl.obolibrary.org/obo/GO_0048015) (phosphatidylinositol-mediated signaling), [GO:0097413](http://purl.obolibrary.org/obo/GO_0097413) (Lewy body), [GO:0031226](http://purl.obolibrary.org/obo/GO_0031226) (intrinsic component of plasma membrane), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0071837](http://purl.obolibrary.org/obo/GO_0071837) (HMG box domain binding), [GO:0015893](http://purl.obolibrary.org/obo/GO_0015893) (drug transport), [GO:0035025](http://purl.obolibrary.org/obo/GO_0035025) (positive regulation of Rho protein signal transduction), [GO:1900273](http://purl.obolibrary.org/obo/GO_1900273) (positive regulation of long-term synaptic potentiation), [GO:0006024](http://purl.obolibrary.org/obo/GO_0006024) (glycosaminoglycan biosynthetic process), [GO:0021654](http://purl.obolibrary.org/obo/GO_0021654) (rhombomere boundary formation), [GO:0043122](http://purl.obolibrary.org/obo/GO_0043122) (regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0009653](http://purl.obolibrary.org/obo/GO_0009653) (anatomical structure morphogenesis), [GO:0048259](http://purl.obolibrary.org/obo/GO_0048259) (regulation of receptor-mediated endocytosis), [GO:0006820](http://purl.obolibrary.org/obo/GO_0006820) (anion transport), [GO:0038091](http://purl.obolibrary.org/obo/GO_0038091) (positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway), [GO:0048936](http://purl.obolibrary.org/obo/GO_0048936) (peripheral nervous system neuron axonogenesis), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0006935](http://purl.obolibrary.org/obo/GO_0006935) (chemotaxis), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:1905719](http://purl.obolibrary.org/obo/GO_1905719) (protein localization to perinuclear region of cytoplasm), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0043130](http://purl.obolibrary.org/obo/GO_0043130) (ubiquitin binding), [GO:0060947](http://purl.obolibrary.org/obo/GO_0060947) (cardiac vascular smooth muscle cell differentiation), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:2000377](http://purl.obolibrary.org/obo/GO_2000377) (regulation of reactive oxygen species metabolic process), [GO:0035019](http://purl.obolibrary.org/obo/GO_0035019) (somatic stem cell population maintenance), [GO:2000379](http://purl.obolibrary.org/obo/GO_2000379) (positive regulation of reactive oxygen species metabolic process), [GO:0048709](http://purl.obolibrary.org/obo/GO_0048709) (oligodendrocyte differentiation), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0021527](http://purl.obolibrary.org/obo/GO_0021527) (spinal cord association neuron differentiation), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0038085](http://purl.obolibrary.org/obo/GO_0038085) (vascular endothelial growth factor binding), [GO:0048706](http://purl.obolibrary.org/obo/GO_0048706) (embryonic skeletal system development), [GO:0042169](http://purl.obolibrary.org/obo/GO_0042169) (SH2 domain binding), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0021915](http://purl.obolibrary.org/obo/GO_0021915) (neural tube development), [GO:0043548](http://purl.obolibrary.org/obo/GO_0043548) (phosphatidylinositol 3-kinase binding), [GO:0044753](http://purl.obolibrary.org/obo/GO_0044753) (amphisome), [GO:0051291](http://purl.obolibrary.org/obo/GO_0051291) (protein heterooligomerization), [GO:0045840](http://purl.obolibrary.org/obo/GO_0045840) (positive regulation of mitotic nuclear division), [GO:0044754](http://purl.obolibrary.org/obo/GO_0044754) (autolysosome), [GO:0045722](http://purl.obolibrary.org/obo/GO_0045722) (positive regulation of gluconeogenesis), [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0071455](http://purl.obolibrary.org/obo/GO_0071455) (cellular response to hyperoxia), [GO:0014813](http://purl.obolibrary.org/obo/GO_0014813) (skeletal muscle satellite cell commitment), [GO:0010453](http://purl.obolibrary.org/obo/GO_0010453) (regulation of cell fate commitment), [GO:0051721](http://purl.obolibrary.org/obo/GO_0051721) (protein phosphatase 2A binding), [GO:0035633](http://purl.obolibrary.org/obo/GO_0035633) (maintenance of permeability of blood-brain barrier), [GO:0021904](http://purl.obolibrary.org/obo/GO_0021904) (dorsal/ventral neural tube patterning), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0060437](http://purl.obolibrary.org/obo/GO_0060437) (lung growth), [GO:0043552](http://purl.obolibrary.org/obo/GO_0043552) (positive regulation of phosphatidylinositol 3-kinase activity), [GO:0045732](http://purl.obolibrary.org/obo/GO_0045732) (positive regulation of protein catabolic process), [GO:0048568](http://purl.obolibrary.org/obo/GO_0048568) (embryonic organ development), [GO:0000423](http://purl.obolibrary.org/obo/GO_0000423) (mitophagy), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0050880](http://purl.obolibrary.org/obo/GO_0050880) (regulation of blood vessel size), [GO:0014707](http://purl.obolibrary.org/obo/GO_0014707) (branchiomeric skeletal muscle development), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:2000288](http://purl.obolibrary.org/obo/GO_2000288) (positive regulation of myoblast proliferation), [GO:0050768](http://purl.obolibrary.org/obo/GO_0050768) (negative regulation of neurogenesis), [GO:0014029](http://purl.obolibrary.org/obo/GO_0014029) (neural crest formation), [GO:0015238](http://purl.obolibrary.org/obo/GO_0015238) (drug transmembrane transporter activity), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0014003](http://purl.obolibrary.org/obo/GO_0014003) (oligodendrocyte development), [GO:0007032](http://purl.obolibrary.org/obo/GO_0007032) (endosome organization), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0097150](http://purl.obolibrary.org/obo/GO_0097150) (neuronal stem cell population maintenance), [GO:0005776](http://purl.obolibrary.org/obo/GO_0005776) (autophagosome), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0001840](http://purl.obolibrary.org/obo/GO_0001840) (neural plate development), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:2000177](http://purl.obolibrary.org/obo/GO_2000177) (regulation of neural precursor cell proliferation), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0014911](http://purl.obolibrary.org/obo/GO_0014911) (positive regulation of smooth muscle cell migration), [GO:0035973](http://purl.obolibrary.org/obo/GO_0035973) (aggrephagy), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0061300](http://purl.obolibrary.org/obo/GO_0061300) (cerebellum vasculature development), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0000407](http://purl.obolibrary.org/obo/GO_0000407) (phagophore assembly site), [GO:1903078](http://purl.obolibrary.org/obo/GO_1903078) (positive regulation of protein localization to plasma membrane), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0006511](http://purl.obolibrary.org/obo/GO_0006511) (ubiquitin-dependent protein catabolic process), [GO:0090090](http://purl.obolibrary.org/obo/GO_0090090) (negative regulation of canonical Wnt signaling pathway), [GO:0014807](http://purl.obolibrary.org/obo/GO_0014807) (regulation of somitogenesis), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0061298](http://purl.obolibrary.org/obo/GO_0061298) (retina vasculature development in camera-type eye), [GO:0061056](http://purl.obolibrary.org/obo/GO_0061056) (sclerotome development), [GO:0035441](http://purl.obolibrary.org/obo/GO_0035441) (cell migration involved in vasculogenesis), [GO:0014068](http://purl.obolibrary.org/obo/GO_0014068) (positive regulation of phosphatidylinositol 3-kinase signaling), [GO:1903243](http://purl.obolibrary.org/obo/GO_1903243) (negative regulation of cardiac muscle hypertrophy in response to stress), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0032967](http://purl.obolibrary.org/obo/GO_0032967) (positive regulation of collagen biosynthetic process), [GO:0007409](http://purl.obolibrary.org/obo/GO_0007409) (axonogenesis), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0035793](http://purl.obolibrary.org/obo/GO_0035793) (positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway), [GO:0035791](http://purl.obolibrary.org/obo/GO_0035791) (platelet-derived growth factor receptor-beta signaling pathway), [GO:0008514](http://purl.obolibrary.org/obo/GO_0008514) (organic anion transmembrane transporter activity), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0032956](http://purl.obolibrary.org/obo/GO_0032956) (regulation of actin cytoskeleton organization), [GO:0035789](http://purl.obolibrary.org/obo/GO_0035789) (metanephric mesenchymal cell migration), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0008286](http://purl.obolibrary.org/obo/GO_0008286) (insulin receptor signaling pathway), [GO:0040011](http://purl.obolibrary.org/obo/GO_0040011) (locomotion), [GO:0031062](http://purl.obolibrary.org/obo/GO_0031062) (positive regulation of histone methylation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0005215](http://purl.obolibrary.org/obo/GO_0005215) (transporter activity), [GO:0043403](http://purl.obolibrary.org/obo/GO_0043403) (skeletal muscle tissue regeneration), [GO:0048659](http://purl.obolibrary.org/obo/GO_0048659) (smooth muscle cell proliferation), [GO:0061635](http://purl.obolibrary.org/obo/GO_0061635) (regulation of protein complex stability), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0071670](http://purl.obolibrary.org/obo/GO_0071670) (smooth muscle cell chemotaxis), [GO:0050730](http://purl.obolibrary.org/obo/GO_0050730) (regulation of peptidyl-tyrosine phosphorylation), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0007626](http://purl.obolibrary.org/obo/GO_0007626) (locomotory behavior), [GO:0097225](http://purl.obolibrary.org/obo/GO_0097225) (sperm midpiece), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0048663](http://purl.obolibrary.org/obo/GO_0048663) (neuron fate commitment), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0016234](http://purl.obolibrary.org/obo/GO_0016234) (inclusion body), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0016235](http://purl.obolibrary.org/obo/GO_0016235) (aggresome), [GO:0016236](http://purl.obolibrary.org/obo/GO_0016236) (macroautophagy), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0009384](http://purl.obolibrary.org/obo/GO_0009384) (N-acylmannosamine kinase activity), [GO:0060415](http://purl.obolibrary.org/obo/GO_0060415) (muscle tissue morphogenesis), [GO:0060538](http://purl.obolibrary.org/obo/GO_0060538) (skeletal muscle organ development), [GO:0046488](http://purl.obolibrary.org/obo/GO_0046488) (phosphatidylinositol metabolic process), [GO:0009267](http://purl.obolibrary.org/obo/GO_0009267) (cellular response to starvation), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0090280](http://purl.obolibrary.org/obo/GO_0090280) (positive regulation of calcium ion import), [GO:0007517](http://purl.obolibrary.org/obo/GO_0007517) (muscle organ development), [GO:0001894](http://purl.obolibrary.org/obo/GO_0001894) (tissue homeostasis), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0003712](http://purl.obolibrary.org/obo/GO_0003712) (transcription cofactor activity), [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development), [GO:0018108](http://purl.obolibrary.org/obo/GO_0018108) (peptidyl-tyrosine phosphorylation), [GO:0016605](http://purl.obolibrary.org/obo/GO_0016605) (PML body), [GO:0000932](http://purl.obolibrary.org/obo/GO_0000932) (P-body), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0001227](http://purl.obolibrary.org/obo/GO_0001227) (transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0021514](http://purl.obolibrary.org/obo/GO_0021514) (ventral spinal cord interneuron differentiation), [GO:0098780](http://purl.obolibrary.org/obo/GO_0098780) (response to mitochondrial depolarisation), [GO:0060842](http://purl.obolibrary.org/obo/GO_0060842) (arterial endothelial cell differentiation), [GO:0001223](http://purl.obolibrary.org/obo/GO_0001223) (transcription coactivator binding), [GO:0042060](http://purl.obolibrary.org/obo/GO_0042060) (wound healing), [GO:0072262](http://purl.obolibrary.org/obo/GO_0072262) (metanephric glomerular mesangial cell proliferation involved in metanephros development), [GO:0035914](http://purl.obolibrary.org/obo/GO_0035914) (skeletal muscle cell differentiation), [GO:0043393](http://purl.obolibrary.org/obo/GO_0043393) (regulation of protein binding), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0071732](http://purl.obolibrary.org/obo/GO_0071732) (cellular response to nitric oxide), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0055003](http://purl.obolibrary.org/obo/GO_0055003) (cardiac myofibril assembly), [GO:0055007](http://purl.obolibrary.org/obo/GO_0055007) (cardiac muscle cell differentiation), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:0021865](http://purl.obolibrary.org/obo/GO_0021865) (symmetric radial glial cell division in forebrain), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0035907](http://purl.obolibrary.org/obo/GO_0035907) (dorsal aorta development), [GO:0010508](http://purl.obolibrary.org/obo/GO_0010508) (positive regulation of autophagy), [GO:0035909](http://purl.obolibrary.org/obo/GO_0035909) (aorta morphogenesis), [GO:0032516](http://purl.obolibrary.org/obo/GO_0032516) (positive regulation of phosphoprotein phosphatase activity), [GO:0007219](http://purl.obolibrary.org/obo/GO_0007219) (Notch signaling pathway), [GO:0044130](http://purl.obolibrary.org/obo/GO_0044130) (negative regulation of growth of symbiont in host), [GO:0006807](http://purl.obolibrary.org/obo/GO_0006807) (nitrogen compound metabolic process), [GO:0010506](http://purl.obolibrary.org/obo/GO_0010506) (regulation of autophagy), [GO:0032873](http://purl.obolibrary.org/obo/GO_0032873) (negative regulation of stress-activated MAPK cascade), [GO:0010863](http://purl.obolibrary.org/obo/GO_0010863) (positive regulation of phospholipase C activity), [GO:0050921](http://purl.obolibrary.org/obo/GO_0050921) (positive regulation of chemotaxis), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0060981](http://purl.obolibrary.org/obo/GO_0060981) (cell migration involved in coronary angiogenesis), [GO:0050938](http://purl.obolibrary.org/obo/GO_0050938) (regulation of xanthophore differentiation), [GO:0015293](http://purl.obolibrary.org/obo/GO_0015293) (symporter activity), [GO:0008761](http://purl.obolibrary.org/obo/GO_0008761) (UDP-N-acetylglucosamine 2-epimerase activity), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0005017](http://purl.obolibrary.org/obo/GO_0005017) (platelet-derived growth factor-activated receptor activity), [GO:0032869](http://purl.obolibrary.org/obo/GO_0032869) (cellular response to insulin stimulus), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0048066](http://purl.obolibrary.org/obo/GO_0048066) (developmental pigmentation), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0050936](http://purl.obolibrary.org/obo/GO_0050936) (xanthophore differentiation), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:2000573](http://purl.obolibrary.org/obo/GO_2000573) (positive regulation of DNA biosynthetic process), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0045599](http://purl.obolibrary.org/obo/GO_0045599) (negative regulation of fat cell differentiation), [GO:0048745](http://purl.obolibrary.org/obo/GO_0048745) (smooth muscle tissue development), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0048747](http://purl.obolibrary.org/obo/GO_0048747) (muscle fiber development), [GO:0005019](http://purl.obolibrary.org/obo/GO_0005019) (platelet-derived growth factor beta-receptor activity), [GO:0070530](http://purl.obolibrary.org/obo/GO_0070530) (K63-linked polyubiquitin modification-dependent protein binding), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0072277](http://purl.obolibrary.org/obo/GO_0072277) (metanephric glomerular capillary formation), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 55.72%
- [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion) 50.62%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 37.02%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) 35.98%
- [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) and [GO:0070161](http://purl.obolibrary.org/obo/GO_0070161) (anchoring junction) 35.98%
- [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction) and [GO:0030055](http://purl.obolibrary.org/obo/GO_0030055) (cell-substrate junction) 35.98%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005037](http://purl.obolibrary.org/obo/GO_0005037) (obsolete death receptor adaptor protein activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 35.98%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005033](http://purl.obolibrary.org/obo/GO_0005033) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 35.98%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005032](http://purl.obolibrary.org/obo/GO_0005032) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 35.98%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005029](http://purl.obolibrary.org/obo/GO_0005029) (obsolete CD27 receptor activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 35.98%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005028](http://purl.obolibrary.org/obo/GO_0005028) (obsolete CD40 receptor activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 35.98%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005027](http://purl.obolibrary.org/obo/GO_0005027) (obsolete NGF/TNF (6 C-domain) receptor activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 35.98%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005023](http://purl.obolibrary.org/obo/GO_0005023) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 35.98%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005016](http://purl.obolibrary.org/obo/GO_0005016) (obsolete neurotrophin TRKC receptor activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 35.98%
- [GO:0005924](http://purl.obolibrary.org/obo/GO_0005924) (cell-substrate adherens junction) and ([GO:0005015](http://purl.obolibrary.org/obo/GO_0005015) (obsolete neurotrophin TRKB receptor activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 35.98%


